A Klebsiella rhizobacterium deregulates the metabolism of phytopathogenic Aspergillus flavus during in-vitro assays and confers protective functions

Abstract

In previous investigations, we have identified a rhizobacterium (Klebsiella sp. MBE02) that confers host protection against several phytopathogenic fungi. For instance, this rhizobacterium prevents Aspergillus flavus infection and promotes peanut growth and fitness in controlled and field-conditions. The mechanistic basis of the protective function offered by this rhizobacterium is not completely understood. MBE02 directly restricts the growth of the pathogenic fungi, which led us to hypothesize that it may strongly dysregulate the metabolism of A. flavus, and inhibit critical metabolic processes of the fungus, which severely restricts pathogen growth. We have tested this hypothesis by using untargeted metabolite profiling. Sixty-nine A. flavus metabolites accumulated differentially due to the presence of the MBE02. MBE02 could inhibit several important metabolic pathways, which include the biosynthesis of critical primary metabolites such as amino acids and fatty acids. It also impacts energy metabolism of the fungus, and that the accumulation of several structural components, including of the cell wall, were strongly inhibited. MBE02 abrogated the accumulation of disease-causing metabolites in A. flavus, whereas the accumulation of metabolites that inhibit fungal growth were enhanced. On the other hand, A. flavus did not strikingly impact the accumulation of metabolites of the MBE02. Our investigation supports the hypothesis that Klebsiella sp. MBE02 mediates protective function by directly impairing the pathogen’s metabolism.